Combined oral medroxyprogesterone (MPA)/levonorgestrel-intrauterine system (LNG-IUS) treatment for women with grade 2 stage IA endometrial cancer of grade 2

被引：0
|
作者：
Kim, M. K. [1 ]
Young, H. Ji [1 ]
Hee, K. Da [1 ]
Sook, H. A. K. Hyo [1 ]
Mi-La, K. [1 ]
Wook, J. Yong [1 ]
Seong, Y. Bo [1 ]
Ju, S. Seok [1 ]
机构：
[1] CHA Univ, CHA Gangnam Med Ctr, Obstet & Gynecol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0435
引用
收藏
页码：1005 / 1005
页数：1
相关论文
共 35 条
  • [1] Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer
    Hwang, Ji Young
    Kim, Da Hee
    Bae, Hyo Sook
    Kim, Mi-La
    Jung, Yong Wook
    Yun, Bo Seong
    Seong, Seok Ju
    Shin, Eunah
    Kim, Mi Kyoung
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) : 738 - 742
  • [2] Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer
    Kim, Mi Kyoung
    Seong, Seok Ju
    Kim, You Shin
    Song, Taejong
    Kim, Mi-La
    Yoon, Bo Sung
    Jun, Hye Sun
    Lee, Yoon Hee
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 209 (04) : 358.e1 - 358.e4
  • [3] The levonorgestrel intrauterine system (LNG-IUS) for prevention of endometrial cancer in women with obesity is cost effective
    Bernard, Laurence
    Kwon, Janice
    Simpson, Andrea
    Ferguson, Sarah
    Sinasac, Sarah
    Pina, Annick
    Reade, Clare
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S300 - S301
  • [4] The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
    Chen, Xiaojun
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (04)
  • [5] MANAGEMENT OF EARLY-STAGE ENDOMETRIAL CANCER IN YOUNG WOMEN WITH COMBINED ORAL MEDROXYPROGESTERONE/LEVONORGESTREL-INTRAUTERINE SYSTEM: A KOREAN GYNECOLOGIC-ONCOLOGY GROUP STUDY
    Kim, M. K.
    Soon-Beom, K.
    Duk-Soo, B.
    Jae-Weon, K.
    Joo-Hyun, N.
    Cheol, L. Myong
    Sang, L. Taek
    Sunghoon, K.
    Jiheum, P.
    Ju, S. Seok
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 54 - 54
  • [6] Levonorgestrel-releasing intrauterine system (LNG-IUS) versus oral medroxyprogesterone acetate (MPA) in infertile women with endometrial hyperplasia without atypia: prospective evaluation of regression rates and live-birth rates
    Vanni, V. S.
    Campo, G.
    Papaleo, E.
    Turba, F.
    Casiero, D.
    Sajdak, M.
    Villanacci, R.
    Quaranta, L.
    Pasi, F.
    Scarrone, M.
    Bordoli, S.
    Canti, V.
    Candiani, M.
    Rovere-Querini, P.
    Giardina, P.
    HUMAN REPRODUCTION, 2020, 35 : 12 - 12
  • [7] Levonorgestril Intrauterine System (LNG-IUS) Versus Medroxyprogesterone Acetate for the Treatment of Endometrial Hyperplasia: A Randomized Control Trial
    Rizvi, Sarwat
    Ghaffar, Shanza
    Haider, Rubar
    Jafri, Anum
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (02): : 675 - 678
  • [8] Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women
    Hampton, NRE
    Rees, MCP
    Lowe, DG
    Rauramo, I
    Barlow, D
    Guillebaud, J
    HUMAN REPRODUCTION, 2005, 20 (09) : 2653 - 2660
  • [9] AN EVALUATION OF THE SIMULTANEOUS USE OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) COMBINED WITH ENDOMETRIAL ABLATION IN THE MANAGEMENT OF MENORRHAGIA
    Vaughan, D. A.
    Byrne, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : 154 - 154
  • [10] Six months response rate of combined oral medroxyprogesterone / levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study
    Kim, Mi Kyoung
    Seong, Seok Ju
    Kang, Soon-Beom
    Bae, Duk-Soo
    Kim, Jae-Weon
    Nam, Joo-Hyun
    Lim, Myong Cheol
    Lee, Taek Sang
    Kim, Sunghoon
    Paek, Jiheum
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (02)
1234